Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL2107834

RIOCIGUAT
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N

Basic Information

ChEMBL ID CHEMBL2107834
Name RIOCIGUAT
Phase Approved
Structure Type MOL
InChI Key WXXSNCNJFUAIDG-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Adempas BAY 63-2521 BAY-63-2521 Riociguat
4
Targets
5
Activities
2
Assay Types
9
PK Parameters
20
Publications
4
Known Names
13
Indications
1
Mechanisms

Molecular Properties

422.4
MW (Da)
2.44
ALogP
9
HBA
2
HBD
138.1
PSA (Ų)
0.51
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2013
Availability Prescription
Chirality Achiral

Routes of Administration

Oral

Flags

Black Box Warning First in Class
USAN Stem -ciguat
USAN Year 2012

Extended Properties

Molecular Formula C20H19FN8O2
MW 422.42
Aromatic Rings 4
Heavy Atoms 31
NP-Likeness -1.62

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Soluble guanylate cyclase positive allosteric modulator POSITIVE ALLOSTERIC MODULATOR Soluble guanylate cyclase

Indications

Familial Primary Pulmonary Hypertension Hypertension Hypertension, Pulmonary Hypertension, Pulmonary Anemia, Sickle Cell Coronary Disease Cystic Fibrosis Ischemic Stroke Raynaud Disease Scleroderma, Localized Scleroderma, Systemic Ulcer HIV Infections

ATC Classification

C02KX05
riociguat
Level 1: CARDIOVASCULAR SYSTEM
Level 2: ANTIHYPERTENSIVES

Drug Warnings

Black Box Warning
teratogenicity
Country: United States

Activity Summary

EC50 3 meas. best 6.75
IC50 2 meas. best 6.92

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Aorta
CHEMBL4651286
IC50 6.92 6.92 120.0 1
Unchecked
CHEMBL612545
IC50 6.92 6.92 120.0 1
Aorta
CHEMBL613606
EC50 6.75 6.75 180.0 1
Heart
CHEMBL613629
EC50 6.57 6.57 270.0 1
Unchecked
CHEMBL612545
EC50 6.52 6.52 300.0 1

Pharmacokinetic Data

Parameter Value Units Species
CL 3.333 mL.min-1.kg-1 Rattus norvegicus
CL 5.0 mL.min-1.kg-1 Canis lupus familiaris
CL 21.67 mL.min-1.kg-1 Rattus norvegicus
F 79.0 % Canis lupus familiaris
F 46.0 % Rattus norvegicus
T1/2 2.4 hr Canis lupus familiaris
T1/2 1.4 hr Rattus norvegicus
T1/2 5.0 hr Homo sapiens
Tmax 0.5 hr Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
32914624 10.1021/acs.jmedchem.0c01132 Unchecked 10
32914624 10.1021/acs.jmedchem.0c01132 Rattus norvegicus 6
28557445 10.1021/acs.jmedchem.7b00449 Canis familiaris 4
28557445 10.1021/acs.jmedchem.7b00449 Rattus norvegicus 4
39058542 10.1021/acs.jmedchem.4c01364 Rattus norvegicus 4
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
32914624 10.1021/acs.jmedchem.0c01132 AMP-activated protein kinase, AMPK 4
39058542 10.1021/acs.jmedchem.4c01364 Unchecked 3
37468498 10.1038/s41467-023-40064-9 Thromboxane A2 receptor 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M1 2
37468498 10.1038/s41467-023-40064-9 Prostaglandin G/H synthase 1 2
33314936 10.1021/acs.jmedchem.0c01093 ADMET 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
32914624 10.1021/acs.jmedchem.0c01132 Aorta 2
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 2
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 2
30995566 10.1016/j.ejmech.2019.04.014 Unchecked 2
33314936 10.1021/acs.jmedchem.0c01093 Unchecked 1
- 10.21203/rs.3.rs-23951/v1 SARS-CoV-2 1
28557445 10.1021/acs.jmedchem.7b00449 ADMET 1

Data from ChEMBL 36 via Core Engine